載入...
Academic oncology clinicians’ understanding of biosimilars and information needed before prescribing
BACKGROUND: With increasing numbers of oncology biosimilars in the approval pipeline, it is important to investigate oncology clinicians’ understanding of biosimilars and what information they need prior to adoption. METHODS: Between January and May 2018, 77 oncology clinicians (52 physicians, 16 ph...
Na minha lista:
| 發表在: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327341/ https://ncbi.nlm.nih.gov/pubmed/30671144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918818335 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|